Fred Schwarzer | CEO |
Misbah Tahir | CFO |
Bruce Keyt | Chief Scientific Officer |
Dan Chen | Chief Medical Officer |
Stephen Willey | Stifel Nicolaus |
Michael Schmidt | Guggenheim |
Good day, everyone and welcome to the IGM Biosciences Fourth Quarter and Full Year 2019 Financial Results. Today's call is being recorded.
At this time, I'd now like to turn the call over to Misbah Tahir, Chief Financial Officer of IGM.
Thank you, operator. Welcome and thank you to those of you joining us today to discuss IGM's fourth quarter and full year 2019 financial results.